NDC Product Labeler Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. labeler's code is 61755. The labeler has 46 products that have an assigned National Drug Code.

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Product Type	Status
61755-005	Eylea	Aflibercept	Injection, Solution	Intravitreal	Human Prescription Drug	ACTIVE
61755-008	Libtayo	Cemiplimab-rwlc	Injection	Intravenous	Human Prescription Drug	ACTIVE
61755-010	Evkeeza	Evinacumab	Injection, Solution, Concentrate	Intravenous	Human Prescription Drug	ACTIVE
61755-013	Evkeeza	Evinacumab	Injection, Solution, Concentrate	Intravenous	Human Prescription Drug	ACTIVE
61755-014	Veopoz	Pozelimab	Injection, Solution	Intravenous; Subcutaneous	Human Prescription Drug	ACTIVE
61755-018	Inmazeb	Atoltivimab, Maftivimab, And Odesivimab-ebgn	Injection, Solution	Intravenous	Human Prescription Drug	ACTIVE
61755-019	Inmazeb	Atoltivimab, Maftivimab, And Odesivimab-ebgn	Injection, Solution	Intravenous	Human Prescription Drug	ACTIVE
61755-020	Praluent	Alirocumab	Injection, Solution	Subcutaneous	Human Prescription Drug	ACTIVE
61755-021	Praluent	Alirocumab	Injection, Solution	Subcutaneous	Human Prescription Drug	ACTIVE
61755-050	Eylea Hd	Aflibercept	Injection, Solution	Intravitreal	Human Prescription Drug	ACTIVE
61755-051	Eylea Hd	Aflibercept	Injection, Solution	Intravitreal	Human Prescription Drug	ACTIVE
61755-054	Lynozyfic	Linvoseltamab-gcpt	Injection, Solution, Concentrate	Intravenous	Human Prescription Drug	ACTIVE
61755-056	Lynozyfic	Linvoseltamab-gcpt	Injection, Solution, Concentrate	Intravenous	Human Prescription Drug	ACTIVE
61755-001	Arcalyst
61755-007	Libtayo
61755-024	Casirivimab
61755-025	Imdevimab
61755-026	Casirivimab
61755-027	Imdevimab
61755-035	Regen-cov
61755-036	Regen-cov
61755-037	Regen-cov
61755-038	Regen-cov
61755-039	Regen-cov
61755-042	Casirivimab With Imdevimab
61755-045	Casirivimab With Imdevimab
61755-905		Aflibercept	Injection, Solution		Drug For Further Processing	UNFINISHED
61755-908		Cemiplimab	Solution		Drug For Further Processing	UNFINISHED
61755-909		Cemiplimab	Solution		Drug For Further Processing	UNFINISHED
61755-910		Evinacumab	Solution		Drug For Further Processing	UNFINISHED
61755-914		Pozelimab	Injection, Solution		Drug For Further Processing	UNFINISHED
61755-921		Alirocumab	Injection, Solution		Drug For Further Processing	UNFINISHED
61755-923		Sarilumab	Injection, Solution		Drug For Further Processing	UNFINISHED
61755-924		Sarilumab	Injection, Solution		Drug For Further Processing	UNFINISHED
61755-930		Aflibercept	Injection, Solution		Drug For Further Processing	UNFINISHED
61755-931		Rilonacept	Injection, Powder, Lyophilized, For Solution		Drug For Further Processing	UNFINISHED
61755-940		Dupilumab	Injection, Solution		Drug For Further Processing	UNFINISHED
61755-941		Dupilumab	Injection, Solution		Drug For Further Processing	UNFINISHED
61755-950		Aflibercept	Injection, Solution		Drug For Further Processing	UNFINISHED
61755-954		Linvoseltamab	Solution		Human Prescription Drug	UNFINISHED
61755-960		Atoltivimab	Injection, Solution		Drug For Further Processing	UNFINISHED
61755-961		Maftivimab	Injection, Solution		Drug For Further Processing	UNFINISHED
61755-962		Odesivimab	Injection, Solution		Drug For Further Processing	UNFINISHED
61755-963		Atoltivimab	Injection, Solution		Drug For Further Processing	UNFINISHED
61755-964		Maftivimab	Injection, Solution		Drug For Further Processing	UNFINISHED
61755-965		Odesivimab	Injection, Solution		Drug For Further Processing	UNFINISHED